Purpose Intrahepatic recurrence has a significant effect on the survival of hepatocellular
carcinoma (HCC) patients. We aimed to determine if there are useful indicators in predicting …

Background Preoperative α-fetoprotein (AFP) level levels may help select patients with
hepatocellular carcinoma (HCC) for surgery. The objective of the current study was to …

Background Many patients with hepatocellular carcinoma (HCC) who undergo liver
transplantation (LT) subsequently develop tumor recurrence; this is the main factor affecting …

Objective To study the relationship between preoperative serum a-fetoprotein (AFP) level
and early recurrence of patients with hepatocellular carcinoma (HCC) after partial …

AIM To investigate the impact of alpha-fetoprotein (AFP) on long-term recurrence rate and
overall survival and we also aimed to define the level of AFP leading to a higher risk of …

BACKGROUND: Liver transplantation (LT) offers a possible cure for patients with
hepatocellular carcinoma (HCC) and cirrhosis. However, tumour progression while on the …

Background High alpha-fetoprotein (AFP) expressions (> 400 ng/mL) are associated with
poor oncological characteristics for hepatocellular carcinoma (HCC). However, prognosis …

AIMS: Alpha-fetoprotein (AFP) loses its potentials in treatment evaluation and prognosis
prediction in patients with AFP negative (≤ 20 ng/ml) hepatocellular carcinoma (HCC). The …

Background Milan criteria (MC) represent the most commonly adopted criteria for the
selection of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation …

Background Alpha-fetoprotein has been used as a predictor of recurrence for hepatocellular
carcinoma and disease-free survival post-resection. Studies in East Asia have shown that …